BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Omenetti A, Bass LM, Anders RA, Clemente MG, Francis H, Guy CD, McCall S, Choi SS, Alpini G, Schwarz KB. Hedgehog activity, epithelial-mesenchymal transitions, and biliary dysmorphogenesis in biliary atresia. Hepatology. 2011;53:1246-1258. [PMID: 21480329 DOI: 10.1002/hep.24156] [Cited by in Crossref: 77] [Cited by in F6Publishing: 74] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Davey MG, McTeir L, Barrie AM, Freem LJ, Stephen LA. Loss of cilia causes embryonic lung hypoplasia, liver fibrosis, and cholestasis in the talpid3 ciliopathy mutant. Organogenesis 2014;10:177-85. [PMID: 24743779 DOI: 10.4161/org.28819] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
2 Bohinc BN, Diehl AM. Mechanisms of disease progression in NASH: new paradigms. Clin Liver Dis. 2012;16:549-565. [PMID: 22824480 DOI: 10.1016/j.cld.2012.05.002] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 5.2] [Reference Citation Analysis]
3 Lepreux S, Desmoulière A. Human liver myofibroblasts during development and diseases with a focus on portal (myo)fibroblasts. Front Physiol. 2015;6:173. [PMID: 26157391 DOI: 10.3389/fphys.2015.00173] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.9] [Reference Citation Analysis]
4 Asai A, Malladi S, Misch J, Pan X, Malladi P, Diehl AM, Whitington PF. Elaboration of tubules with active hedgehog drives parenchymal fibrogenesis in gestational alloimmune liver disease. Human Pathology 2015;46:84-93. [DOI: 10.1016/j.humpath.2014.09.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Sung R, Lee SH, Ji M, Han JH, Kang MH, Kim JH, Choi JW, Kim YC, Park SM. Epithelial-mesenchymal transition-related protein expression in biliary epithelial cells associated with hepatolithiasis. J Gastroenterol Hepatol. 2014;29:395-402. [PMID: 23927024 DOI: 10.1111/jgh.12349] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
6 Jung HY, Jing J, Lee KB, Jang JJ. Sonic hedgehog (SHH) and glioblastoma-2 (Gli-2) expressions are associated with poor jaundice-free survival in biliary atresia. J Pediatr Surg 2015;50:371-6. [PMID: 25746691 DOI: 10.1016/j.jpedsurg.2014.08.025] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
7 Mezina A, Karpen SJ. Genetic contributors and modifiers of biliary atresia. Dig Dis 2015;33:408-14. [PMID: 26045276 DOI: 10.1159/000371694] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
8 Zhao J, Tang N, Wu K, Dai W, Ye C, Shi J, Zhang J, Ning B, Zeng X, Lin Y. MiR-21 simultaneously regulates ERK1 signaling in HSC activation and hepatocyte EMT in hepatic fibrosis. PLoS One. 2014;9:e108005. [PMID: 25303175 DOI: 10.1371/journal.pone.0108005] [Cited by in Crossref: 69] [Cited by in F6Publishing: 68] [Article Influence: 8.6] [Reference Citation Analysis]
9 Cheung AC, Lorenzo Pisarello MJ, LaRusso NF. Pathobiology of biliary epithelia. Biochim Biophys Acta Mol Basis Dis 2018;1864:1220-31. [PMID: 28716705 DOI: 10.1016/j.bbadis.2017.06.024] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
10 Petersen C, Davenport M. Aetiology of biliary atresia: what is actually known? Orphanet J Rare Dis 2013;8:128. [PMID: 23987231 DOI: 10.1186/1750-1172-8-128] [Cited by in Crossref: 72] [Cited by in F6Publishing: 53] [Article Influence: 8.0] [Reference Citation Analysis]
11 Jensen K, Marzioni M, Munshi K, Afroze S, Alpini G, Glaser S. Autocrine regulation of biliary pathology by activated cholangiocytes. Am J Physiol Gastrointest Liver Physiol 2012;302:G473-83. [PMID: 22194419 DOI: 10.1152/ajpgi.00482.2011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
12 Tang V, Cofer ZC, Cui S, Sapp V, Loomes KM, Matthews RP. Loss of a Candidate Biliary Atresia Susceptibility Gene, add3a, Causes Biliary Developmental Defects in Zebrafish. J Pediatr Gastroenterol Nutr 2016;63:524-30. [PMID: 27526058 DOI: 10.1097/MPG.0000000000001375] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 4.2] [Reference Citation Analysis]
13 Bai MR, Niu WB, Zhou Y, Gong YM, Lu YJ, Yu XX, Wei ZL, Wu W, Song HL, Yu WW, Gu BL, Cai W, Chu X. Association of common variation in ADD3 and GPC1 with biliary atresia susceptibility. Aging (Albany NY) 2020;12:7163-82. [PMID: 32315284 DOI: 10.18632/aging.103067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Pozniak KN, Pearen MA, Pereira TN, Kramer CSM, Kalita-De Croft P, Nawaratna SK, Fernandez-Rojo MA, Gobert GN, Tirnitz-Parker JEE, Olynyk JK, Shepherd RW, Lewindon PJ, Ramm GA. Taurocholate Induces Biliary Differentiation of Liver Progenitor Cells Causing Hepatic Stellate Cell Chemotaxis in the Ductular Reaction: Role in Pediatric Cystic Fibrosis Liver Disease. Am J Pathol. 2017;187:2744-2757. [PMID: 28935574 DOI: 10.1016/j.ajpath.2017.08.024] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
15 Yang JJ, Tao H, Li J. Hedgehog signaling pathway as key player in liver fibrosis: new insights and perspectives. Expert Opin Ther Targets. 2014;18:1011-1021. [PMID: 24935558 DOI: 10.1517/14728222.2014.927443] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
16 Pan J, Ho M. Role of glypican-1 in regulating multiple cellular signaling pathways. Am J Physiol Cell Physiol 2021;321:C846-58. [PMID: 34550795 DOI: 10.1152/ajpcell.00290.2021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Ding H, Zhou D, Hao S, Zhou L, He W, Nie J, Hou FF, Liu Y. Sonic hedgehog signaling mediates epithelial-mesenchymal communication and promotes renal fibrosis. J Am Soc Nephrol 2012;23:801-13. [PMID: 22302193 DOI: 10.1681/ASN.2011060614] [Cited by in Crossref: 131] [Cited by in F6Publishing: 85] [Article Influence: 13.1] [Reference Citation Analysis]
18 Fabris L, Spirli C, Cadamuro M, Fiorotto R, Strazzabosco M. Emerging concepts in biliary repair and fibrosis. Am J Physiol Gastrointest Liver Physiol 2017;313:G102-16. [PMID: 28526690 DOI: 10.1152/ajpgi.00452.2016] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 8.4] [Reference Citation Analysis]
19 Machado MV, Diehl AM. Hedgehog signalling in liver pathophysiology. J Hepatol. 2018;68:550-562. [PMID: 29107151 DOI: 10.1016/j.jhep.2017.10.017] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 10.0] [Reference Citation Analysis]
20 Fausther M, Lavoie EG, Dranoff JA. Contribution of Myofibroblasts of Different Origins to Liver Fibrosis. Curr Pathobiol Rep 2013;1:225-30. [PMID: 23997993 DOI: 10.1007/s40139-013-0020-0] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 4.1] [Reference Citation Analysis]
21 Jones H, Hargrove L, Kennedy L, Meng F, Graf-Eaton A, Owens J, Alpini G, Johnson C, Bernuzzi F, Demieville J, DeMorrow S, Invernizzi P, Francis H. Inhibition of mast cell-secreted histamine decreases biliary proliferation and fibrosis in primary sclerosing cholangitis Mdr2(-/-) mice. Hepatology 2016;64:1202-16. [PMID: 27351144 DOI: 10.1002/hep.28704] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 6.8] [Reference Citation Analysis]
22 Zou XZ, Liu T, Gong ZC, Hu CP, Zhang Z. MicroRNAs-mediated epithelial-mesenchymal transition in fibrotic diseases. Eur J Pharmacol 2017;796:190-206. [PMID: 27916556 DOI: 10.1016/j.ejphar.2016.12.003] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 6.7] [Reference Citation Analysis]
23 Lampela H, Kosola S, Heikkilä P, Lohi J, Jalanko H, Pakarinen MP. Native liver histology after successful portoenterostomy in biliary atresia. J Clin Gastroenterol 2014;48:721-8. [PMID: 24275708 DOI: 10.1097/MCG.0000000000000013] [Cited by in Crossref: 29] [Cited by in F6Publishing: 15] [Article Influence: 4.1] [Reference Citation Analysis]
24 Fitzpatrick E. Understanding susceptibility and targeting treatment in non-alcoholic fatty liver disease in children; moving the fulcrum. Proc Nutr Soc 2019;78:362-71. [DOI: 10.1017/s0029665118002914] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
25 Tian L, Ye Z, Kafka K, Stewart D, Anders R, Schwarz KB, Jang YY. Biliary Atresia Relevant Human Induced Pluripotent Stem Cells Recapitulate Key Disease Features in a Dish. J Pediatr Gastroenterol Nutr. 2019;68:56-63. [PMID: 30358741 DOI: 10.1097/mpg.0000000000002187] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
26 Mohammad S, Wolfe LA, Stöbe P, Biskup S, Wainwright MS, Melin-Aldana H, Malladi P, Muenke M, Gahl WA, Whitington PF. Infantile Cirrhosis, Growth Impairment, and Neurodevelopmental Anomalies Associated with Deficiency of PPP1R15B. J Pediatr 2016;179:144-149.e2. [PMID: 27640355 DOI: 10.1016/j.jpeds.2016.08.043] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
27 Taura K, Iwaisako K, Hatano E, Uemoto S. Controversies over the Epithelial-to-Mesenchymal Transition in Liver Fibrosis. J Clin Med 2016;5:E9. [PMID: 26784242 DOI: 10.3390/jcm5010009] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 4.5] [Reference Citation Analysis]
28 Chusilp S, Lee C, Li B, Lee D, Yamoto M, Ganji N, Vejchapipat P, Pierro A. Human amniotic fluid stem cells attenuate cholangiocyte apoptosis in a bile duct injury model of liver ductal organoids. J Pediatr Surg 2021;56:11-6. [PMID: 33129508 DOI: 10.1016/j.jpedsurg.2020.09.043] [Reference Citation Analysis]
29 von Hahn T, Ciesek S, Wegener G, Plentz RR, Weismüller TJ, Wedemeyer H, Manns MP, Greten TF, Malek NP. Epidemiological trends in incidence and mortality of hepatobiliary cancers in Germany. Scandinavian Journal of Gastroenterology 2011;46:1092-8. [DOI: 10.3109/00365521.2011.589472] [Cited by in Crossref: 72] [Cited by in F6Publishing: 71] [Article Influence: 6.5] [Reference Citation Analysis]
30 Asai A, Miethke A, Bezerra JA. Pathogenesis of biliary atresia: defining biology to understand clinical phenotypes. Nat Rev Gastroenterol Hepatol. 2015;12:342-352. [PMID: 26008129 DOI: 10.1038/nrgastro.2015.74] [Cited by in Crossref: 106] [Cited by in F6Publishing: 88] [Article Influence: 15.1] [Reference Citation Analysis]
31 Mavila N, James D, Shivakumar P, Nguyen MV, Utley S, Mak K, Wu A, Zhou S, Wang L, Vendyres C, Groff M, Asahina K, Wang KS. Expansion of prominin-1-expressing cells in association with fibrosis of biliary atresia. Hepatology 2014;60:941-53. [PMID: 24798639 DOI: 10.1002/hep.27203] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
32 Long H, Wang Z, Chen J, Xiang T, Li Q, Diao X, Zhu B. microRNA-214 promotes epithelial-mesenchymal transition and metastasis in lung adenocarcinoma by targeting the suppressor-of-fused protein (Sufu). Oncotarget 2015;6:38705-18. [PMID: 26462018 DOI: 10.18632/oncotarget.5478] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
33 Zagory JA, Nguyen MV, Wang KS. Recent advances in the pathogenesis and management of biliary atresia. Curr Opin Pediatr 2015;27:389-94. [PMID: 25944310 DOI: 10.1097/MOP.0000000000000214] [Cited by in Crossref: 26] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
34 Swiderska-Syn M, Suzuki A, Guy CD, Schwimmer JB, Abdelmalek MF, Lavine JE, Diehl AM. Hedgehog pathway and pediatric nonalcoholic fatty liver disease. Hepatology 2013;57:1814-25. [PMID: 23300059 DOI: 10.1002/hep.26230] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 4.8] [Reference Citation Analysis]
35 Tang S, Jiang X, Wu L, Chen S, Chen L, Jiang J, Yan P, Wang F, Tu K, Wang D, Gu J, Zhao L. Toll-like receptor 4 shRNA attenuates lipopolysaccharide-induced epithelial-mesenchymal transition of intrahepatic biliary epithelial cells in rats. Biomed Pharmacother 2018;107:1210-7. [PMID: 30257335 DOI: 10.1016/j.biopha.2018.08.071] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
36 Jedraszak G, Girard M, Mellos A, Djeddi DD, Chardot C, Vanrenterghem A, Moizard MP, Gondry J, Sevestre H, Mathieu-Dramard M, Lacaille F, Demeer B. A patient with Simpson-Golabi-Behmel syndrome, biliary cirrhosis and successful liver transplantation. Am J Med Genet A 2014;164A:774-7. [PMID: 24357529 DOI: 10.1002/ajmg.a.36335] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
37 Cui S, Leyva-Vega M, Tsai EA, EauClaire SF, Glessner JT, Hakonarson H, Devoto M, Haber BA, Spinner NB, Matthews RP. Evidence from human and zebrafish that GPC1 is a biliary atresia susceptibility gene. Gastroenterology 2013;144:1107-1115.e3. [PMID: 23336978 DOI: 10.1053/j.gastro.2013.01.022] [Cited by in Crossref: 72] [Cited by in F6Publishing: 64] [Article Influence: 8.0] [Reference Citation Analysis]
38 Di Gregorio J, Robuffo I, Spalletta S, Giambuzzi G, De Iuliis V, Toniato E, Martinotti S, Conti P, Flati V. The Epithelial-to-Mesenchymal Transition as a Possible Therapeutic Target in Fibrotic Disorders. Front Cell Dev Biol 2020;8:607483. [PMID: 33409282 DOI: 10.3389/fcell.2020.607483] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
39 Ke J, Zeng S, Mao J, Wang J, Lou J, Li J, Chen X, Liu C, Huang L, Wang B, Liu L. Common genetic variants of GPC1 gene reduce risk of biliary atresia in a Chinese population. Journal of Pediatric Surgery 2016;51:1661-4. [DOI: 10.1016/j.jpedsurg.2016.05.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
40 Santos F, Moreira C, Nóbrega-Pereira S, Bernardes de Jesus B. New Insights into the Role of Epithelial⁻Mesenchymal Transition during Aging. Int J Mol Sci 2019;20:E891. [PMID: 30791369 DOI: 10.3390/ijms20040891] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 5.7] [Reference Citation Analysis]
41 Zhao LJ, Wang F. Epithelial-to-mesenchymal transition and hepatolithiasis. Shijie Huaren Xiaohua Zazhi 2016; 24(8): 1153-1158 [DOI: 10.11569/wcjd.v24.i8.1153] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
42 Zhang RZ, Zeng XH, Lin ZF, Ming-Fu, Tong YL, Lui VC, Tam PK, Lamb JR, Xia HM, Chen Y. Downregulation of Hes1 expression in experimental biliary atresia and its effects on bile duct structure. World J Gastroenterol 2018; 24(29): 3260-3272 [PMID: 30090006 DOI: 10.3748/wjg.v24.i29.3260] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Bezerra JA, Wells RG, Mack CL, Karpen SJ, Hoofnagle JH, Doo E, Sokol RJ. Biliary Atresia: Clinical and Research Challenges for the Twenty-First Century. Hepatology 2018;68:1163-73. [PMID: 29604222 DOI: 10.1002/hep.29905] [Cited by in Crossref: 64] [Cited by in F6Publishing: 62] [Article Influence: 21.3] [Reference Citation Analysis]
44 Xiao Y, Zhou Y, Chen Y, Zhou K, Wen J, Wang Y, Wang J, Cai W. The expression of epithelial-mesenchymal transition-related proteins in biliary epithelial cells is associated with liver fibrosis in biliary atresia. Pediatr Res. 2015;77:310-315. [PMID: 25406900 DOI: 10.1038/pr.2014.181] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
45 Miethke AG, Huppert SS. Fishing for biliary atresia susceptibility genes. Gastroenterology 2013;144:878-81. [PMID: 23523832 DOI: 10.1053/j.gastro.2013.03.017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
46 Omenetti A, Diehl AM. Hedgehog signaling in cholangiocytes. Curr Opin Gastroenterol. 2011;27:268-275. [PMID: 21423008 DOI: 10.1097/mog.0b013e32834550b4] [Cited by in Crossref: 56] [Cited by in F6Publishing: 36] [Article Influence: 5.1] [Reference Citation Analysis]
47 Jiayuan S, Junyan Y, Xiangzhen W, Zuping L, Jian N, Baowei H, Lifang J. Gant61 ameliorates CCl4-induced liver fibrosis by inhibition of Hedgehog signaling activity. Toxicol Appl Pharmacol 2020;387:114853. [PMID: 31816328 DOI: 10.1016/j.taap.2019.114853] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
48 Sun C, Ma Q, Yin J, Zhang H, Liu X. WISP-1 induced by mechanical stress contributes to fibrosis and hypertrophy of the ligamentum flavum through Hedgehog-Gli1 signaling. Exp Mol Med 2021;53:1068-79. [PMID: 34158608 DOI: 10.1038/s12276-021-00636-5] [Reference Citation Analysis]
49 Strazzabosco M, Fabris L. Development of the bile ducts: essentials for the clinical hepatologist. J Hepatol. 2012;56:1159-1170. [PMID: 22245898 DOI: 10.1016/j.jhep.2011.09.022] [Cited by in Crossref: 111] [Cited by in F6Publishing: 95] [Article Influence: 11.1] [Reference Citation Analysis]
50 Yu K, Li Q, Shi G, Li N. Involvement of epithelial-mesenchymal transition in liver fibrosis. Saudi J Gastroenterol 2018;24:5-11. [PMID: 29451178 DOI: 10.4103/sjg.SJG_297_17] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
51 Park SM. The crucial role of cholangiocytes in cholangiopathies. Gut Liver. 2012;6:295-304. [PMID: 22844556 DOI: 10.5009/gnl.2012.6.3.295] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
52 Verdelho Machado M, Diehl AM. Role of Hedgehog Signaling Pathway in NASH. Int J Mol Sci. 2016;17:pii E857. [PMID: 27258259 DOI: 10.3390/ijms17060857] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
53 Ortiz-Perez A, Donnelly B, Temple H, Tiao G, Bansal R, Mohanty SK. Innate Immunity and Pathogenesis of Biliary Atresia. Front Immunol 2020;11:329. [PMID: 32161597 DOI: 10.3389/fimmu.2020.00329] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
54 Kiesslich T, Pichler M, Neureiter D. Epigenetic control of epithelial-mesenchymal-transition in human cancer. Mol Clin Oncol. 2013;1:3-11. [PMID: 24649114 DOI: 10.3892/mco.2012.28] [Cited by in Crossref: 72] [Cited by in F6Publishing: 73] [Article Influence: 7.2] [Reference Citation Analysis]
55 Kerola A, Lampela H, Lohi J, Heikkilä P, Mutanen A, Hagström J, Tervahartiala T, Sorsa T, Haglund C, Jalanko H, Pakarinen MP. Increased MMP-7 expression in biliary epithelium and serum underpins native liver fibrosis after successful portoenterostomy in biliary atresia. J Pathol Clin Res 2016;2:187-98. [PMID: 27499927 DOI: 10.1002/cjp2.50] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.7] [Reference Citation Analysis]
56 Cofer ZC, Cui S, EauClaire SF, Kim C, Tobias JW, Hakonarson H, Loomes KM, Matthews RP. Methylation Microarray Studies Highlight PDGFA Expression as a Factor in Biliary Atresia. PLoS One 2016;11:e0151521. [PMID: 27010479 DOI: 10.1371/journal.pone.0151521] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
57 Xie G, Diehl AM. Evidence for and against epithelial-to-mesenchymal transition in the liver. Am J Physiol Gastrointest Liver Physiol 2013;305:G881-90. [PMID: 24157970 DOI: 10.1152/ajpgi.00289.2013] [Cited by in Crossref: 57] [Cited by in F6Publishing: 61] [Article Influence: 6.3] [Reference Citation Analysis]
58 Wang HW, Shi L, Xu YP, Qin XY, Wang QZ. Hesperetin alleviates renal interstitial fibrosis by inhibiting tubular epithelial-mesenchymal transition in vivo and in vitro. Exp Ther Med 2017;14:3713-9. [PMID: 29042968 DOI: 10.3892/etm.2017.4968] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
59 Peng SS, Jeng YM, Hsu WM, Yang JC, Ho MC. Hepatic ADC map as an adjunct to conventional abdominal MRI to evaluate hepatic fibrotic and clinical cirrhotic severity in biliary atresia patients. Eur Radiol 2015;25:2992-3002. [PMID: 25921590 DOI: 10.1007/s00330-015-3716-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
60 Steinman JB, Salomao MA, Pajvani UB. Zonation in NASH - A key paradigm for understanding pathophysiology and clinical outcomes. Liver Int 2021. [PMID: 34328687 DOI: 10.1111/liv.15025] [Reference Citation Analysis]
61 Yan J, Huang H, Liu Z, Shen J, Ni J, Han J, Wang R, Lin D, Hu B, Jin L. Hedgehog signaling pathway regulates hexavalent chromium-induced liver fibrosis by activation of hepatic stellate cells. Toxicol Lett 2020;320:1-8. [PMID: 31756458 DOI: 10.1016/j.toxlet.2019.11.017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
62 Kietzmann T. Metabolic zonation of the liver: The oxygen gradient revisited. Redox Biol. 2017;11:622-630. [PMID: 28126520 DOI: 10.1016/j.redox.2017.01.012] [Cited by in Crossref: 171] [Cited by in F6Publishing: 164] [Article Influence: 34.2] [Reference Citation Analysis]
63 Chung-Davidson YW, Ren J, Yeh CY, Bussy U, Huerta B, Davidson PJ, Whyard S, Li W. TGF-β Signaling Plays a Pivotal Role During Developmental Biliary Atresia in Sea Lamprey (Petromyzon marinus). Hepatol Commun 2020;4:219-34. [PMID: 32025607 DOI: 10.1002/hep4.1461] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
64 Feldman AG, Mack CL. Biliary Atresia: Clinical Lessons Learned. J Pediatr Gastroenterol Nutr 2015;61:167-75. [PMID: 25658057 DOI: 10.1097/MPG.0000000000000755] [Cited by in Crossref: 51] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
65 Chaudhari P, Tian L, Ye Z, Jang YY. Human-relevant preclinical in vitro models for studying hepatobiliary development and liver diseases using induced pluripotent stem cells. Exp Biol Med (Maywood) 2019;244:702-8. [PMID: 30803263 DOI: 10.1177/1535370219834895] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
66 Kim Y, Kim MO, Shin JS, Park SH, Kim SB, Kim J, Park SC, Han CJ, Ryu JK, Yoon YB. Hedgehog signaling between cancer cells and hepatic stellate cells in promoting cholangiocarcinoma. Ann Surg Oncol. 2014;21:2684-2698. [PMID: 24682719 DOI: 10.1245/s10434-014-3531-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 71] [Article Influence: 3.0] [Reference Citation Analysis]
67 Pereira TA, Xie G, Choi SS, Syn WK, Voieta I, Lu J, Chan IS, Swiderska M, Amaral KB, Antunes CM, Secor WE, Witek RP, Lambertucci JR, Pereira FL, Diehl AM. Macrophage-derived Hedgehog ligands promotes fibrogenic and angiogenic responses in human schistosomiasis mansoni. Liver Int 2013;33:149-61. [PMID: 23121638 DOI: 10.1111/liv.12016] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 4.4] [Reference Citation Analysis]
68 Fabris L, Brivio S, Cadamuro M, Strazzabosco M. Revisiting Epithelial-to-Mesenchymal Transition in Liver Fibrosis: Clues for a Better Understanding of the "Reactive" Biliary Epithelial Phenotype. Stem Cells Int 2016;2016:2953727. [PMID: 26880950 DOI: 10.1155/2016/2953727] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
69 Pham DH, Zhang C, Yin C. Using zebrafish to model liver diseases-Where do we stand? Curr Pathobiol Rep 2017;5:207-21. [PMID: 29098121 DOI: 10.1007/s40139-017-0141-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
70 Pham DH, Yin C. Zebrafish as a Model to Study Cholestatic Liver Diseases. Methods Mol Biol 2019;1981:273-89. [PMID: 31016661 DOI: 10.1007/978-1-4939-9420-5_18] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
71 Witte MH, Dellinger MT, Papendieck CM, Boccardo F. Overlapping biomarkers, pathways, processes and syndromes in lymphatic development, growth and neoplasia. Clin Exp Metastasis 2012;29:707-27. [PMID: 22798218 DOI: 10.1007/s10585-012-9493-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
72 Nielsen J, Christensen VB, Borgwardt L, Rasmussen A, Østrup O, Kjær MS. Prognostic molecular markers in pediatric liver disease – Are there any? Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2019;1865:577-86. [DOI: 10.1016/j.bbadis.2018.12.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
73 Cofer ZC, Matthews RP. Zebrafish Models of Biliary Atresia and Other Infantile Cholestatic Diseases. Curr Pathobiol Rep 2014;2:75-83. [DOI: 10.1007/s40139-014-0040-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
74 Verdelho Machado M, Diehl AM. The hedgehog pathway in nonalcoholic fatty liver disease. Crit Rev Biochem Mol Biol 2018;53:264-78. [PMID: 29557675 DOI: 10.1080/10409238.2018.1448752] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]